Establishing reference ranges for circulating biomarkers of drug‐induced liver injury in healthy human volunteers 1
British Journal of Clinical Pharmacology · 2025-05 · 91 (5) · 1361-1369
DOI: 10.1111/bcp.16371 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 15.12.2024. Verfasst von Andrea L Jorgensen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Data Science, Institute of Population Health, University of Liverpool, Liverpool, UK. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Liverpool and Broad Green University Hospital Trust as part of the UKCRN Portfolio Study, TransBioLine Project who received funding from the Innovative Medicines Initiative 2 Joint Undertaking, Research and Development.
Abstract (Originalsprache)
Aims
The potential of mechanistic biomarkers to improve prediction of drug‐induced liver injury (DILI) and hepatic regeneration is widely acknowledged. We sought to determine reference intervals for new biomarkers of DILI and regeneration, as well as to characterize their natural variability and impact of diurnal variation.
Methods
Serum samples from 227 healthy volunteers were recruited as part of a cross‐sectional study; of these, 25 subjects had weekly serial sampling over 3 weeks, while 23 had intensive blood sampling over a 24h period. Alanine aminotransferase (ALT), MicroRNA‐122 (miR‐122), High Mobility Group Box‐1 (HMGB1), total Keratin‐18 (K18), caspase‐cleaved Keratin‐18 (ccK18), Glutamate Dehydrogenase (GLDH) and Macrophage Colony‐Stimulating Factor‐1 (CSF‐1) were assayed.
Results
Reference intervals were established for each biomarker based on the 97.5% quantile (90% CI) following the assessment of fixed effects in univariate and multivariable models. Intra‐individual variability was found to be non‐significant, and there was no significant impact of diurnal variation.
Conclusion
Reference intervals for novel DILI biomarkers have been described. An upper limit of a reference range might represent the most appropriate mechanism to utilize these data. These data can now be used to interpret data from exploratory clinical DILI studies and to assist their further qualification as required by regulatory authorities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Data Science, Institute of Population Health, University of Liverpool, Liverpool, UK.
- Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Molecular & Clinical Pharmacology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
ORCID-Profile: Samantha Korver, Munir Pirmohamed
Förderung
- Royal Liverpool and Broad Green University Hospital Trust as part of the UKCRN Portfolio Study
- TransBioLine Project who received funding from the Innovative Medicines Initiative 2 Joint Undertaking
- Research and Development
- Innovative Medicines Initiative
- European Union
- Horizon 2020
- University of Liverpool
- Medical Research Council
Zitieren
APA
Jorgensen, A. L., Korver, S., Schofield, A., Howell, L., Clarke, J. I., Walker, L. E., Brillant, N., Goldring, C. E. P., & Pirmohamed, M. (2025). Establishing reference ranges for circulating biomarkers of drug‐induced liver injury in healthy human volunteers 1. British Journal of Clinical Pharmacology, 91(5), 1361-1369. https://doi.org/10.1111/bcp.16371
Vancouver
Jorgensen AL, Korver S, Schofield A, Howell L, Clarke JI, Walker LE, et al. Establishing reference ranges for circulating biomarkers of drug‐induced liver injury in healthy human volunteers 1. British Journal of Clinical Pharmacology. 2025;91(5):1361-1369. doi:10.1111/bcp.16371
BibTeX
@article{Jorgensen2025,
author = {Jorgensen, Andrea L and Korver, Samantha and Schofield, Amy and Howell, Lawrence and Clarke, Joanna I and Walker, Lauren E and Brillant, Nathalie and Goldring, Chris E P and Pirmohamed, Munir},
title = {Establishing reference ranges for circulating biomarkers of drug‐induced liver injury in healthy human volunteers 1},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
volume = {91},
number = {5},
pages = {1361--1369},
doi = {10.1111/bcp.16371}
}
EUVIMED